Literature DB >> 21395404

Toward a new age of cellular pharmacokinetics in drug discovery.

Fang Zhou1, Jingwei Zhang, Peng Li, Fang Niu, Xiaolan Wu, Guangji Wang, Michael S Roberts.   

Abstract

Pharmacokinetics, pharmacology, and toxicology are the major determinants of the success or failure of candidates during drug development. Because inappropriate pharmacokinetics often leads to inefficacy, even toxicity, pharmacokinetics studies have been regarded as crucial components in drug preclinical and clinical research. However, new data increasingly reveal that drug concentrations in plasma or tissues cannot totally explain the efficacy of drug on the target organ. For most drugs that interact with targets localized in cells, intracellular penetration, accumulation, distribution, and elimination are important parameters governing the efficacy in the target cells. So, there is a pressing need to clarify the cellular pharmacokinetics and thus evaluate the efficacy of drugs in the target cells. This review provides a general overview regarding current knowledge about cellular pharmacokinetics in some specific cells and also summarizes the factors that can influence cellular pharmacokinetics. It concludes by discussing potential strategies for optimizing cellular pharmacokinetics and advocating that global cellular pharmacokinetics studies be conducted in future research toward improving drug efficacy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21395404     DOI: 10.3109/03602532.2011.560607

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  14 in total

1.  Determination of intracellular unbound concentrations and subcellular localization of drugs in rat sandwich-cultured hepatocytes compared with liver tissue.

Authors:  Nathan D Pfeifer; Kevin B Harris; Grace Zhixia Yan; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2013-08-29       Impact factor: 3.922

2.  Epithelial delamination is protective during pharmaceutical-induced enteropathy.

Authors:  Scott T Espenschied; Mark R Cronan; Molly A Matty; Olaf Mueller; Matthew R Redinbo; David M Tobin; John F Rawls
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-07       Impact factor: 11.205

3.  Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells.

Authors:  Jingwei Zhang; Fang Zhou; Xiaolan Wu; Xiaoxuan Zhang; Yuancheng Chen; Beth S Zha; Fang Niu; Meng Lu; Gang Hao; Yuan Sun; Jianguo Sun; Ying Peng; Guangji Wang
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

4.  Shenmai injection enhances the cytotoxicity of chemotherapeutic drugs against colorectal cancers via improving their subcellular distribution.

Authors:  Wen-Yue Liu; Jing-Wei Zhang; Xue-Quan Yao; Chao Jiang; Ji-Chao He; Pin Ni; Jia-Li Liu; Qian-Ying Chen; Qing-Ran Li; Xiao-Jie Zang; Lan Yao; Ya-Zhong Liu; Mu-Lan Wang; Pei-Qiang Shen; Guang-Ji Wang; Fang Zhou
Journal:  Acta Pharmacol Sin       Date:  2016-11-21       Impact factor: 6.150

Review 5.  Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver.

Authors:  X Chu; K Korzekwa; R Elsby; K Fenner; A Galetin; Y Lai; P Matsson; A Moss; S Nagar; G R Rosania; J P F Bai; J W Polli; Y Sugiyama; K L R Brouwer
Journal:  Clin Pharmacol Ther       Date:  2013-04-10       Impact factor: 6.875

6.  Brain Distribution of Drugs: Pharmacokinetic Considerations.

Authors:  Irena Loryan; Margareta Hammarlund-Udenaes; Stina Syvänen
Journal:  Handb Exp Pharmacol       Date:  2022

7.  Tumoral expression of drug and xenobiotic metabolizing enzymes in breast cancer patients of different ethnicities with implications to personalized medicine.

Authors:  Yan Li; Albert Steppi; Yidong Zhou; Feng Mao; Philip Craig Miller; Max M He; Tingting Zhao; Qiang Sun; Jinfeng Zhang
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

8.  Alterations in cellular pharmacokinetics and pharmacodynamics of elvitegravir in response to ethanol exposure in HIV-1 infected monocytic (U1) cells.

Authors:  Narasimha M Midde; Namita Sinha; Pradeep B Lukka; Bernd Meibohm; Santosh Kumar
Journal:  PLoS One       Date:  2017-02-23       Impact factor: 3.240

9.  Comparative cellular pharmacokinetics and pharmacodynamics of siRNA delivery by SPANosomes and by cationic liposomes.

Authors:  Chenguang Zhou; Yue Zhang; Bo Yu; Mitch A Phelps; L James Lee; Robert J Lee
Journal:  Nanomedicine       Date:  2012-10-29       Impact factor: 5.307

10.  Semi-Mechanism-Based Pharmacodynamic Model for the Anti-Inflammatory Effect of Baicalein in LPS-Stimulated RAW264.7 Macrophages.

Authors:  Li Xiang; Ying-Fan Hu; Jia-Si Wu; Li Wang; Wen-Ge Huang; Chen-Si Xu; Xian-Li Meng; Ping Wang
Journal:  Front Pharmacol       Date:  2018-07-18       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.